Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Basilea Pharmaceutica AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.63% vs -0.20% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -13.22% vs 277.94% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.60",
          "val2": "147.80",
          "chgp": "6.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.70",
          "val2": "19.40",
          "chgp": "17.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.60",
          "val2": "11.00",
          "chgp": "41.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.50",
          "val2": "12.10",
          "chgp": "-13.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.80%",
          "val2": "110.60%",
          "chgp": "1.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

157.60

147.80

6.63%

Operating Profit (PBDIT) excl Other Income

22.70

19.40

17.01%

Interest

15.60

11.00

41.82%

Exceptional Items

0.00

-0.00

Consolidate Net Profit

10.50

12.10

-13.22%

Operating Profit Margin (Excl OI)

121.80%

110.60%

1.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 6.63% vs -0.20% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -13.22% vs 277.94% in Dec 2022

All Annual Results